Ohr Pharmaceutical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch OHRP and buy or sell other stocks, options, and ETFs commission-free!

About OHRP

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. 

CEO
Dietrich A. Stephan, PhD
CEODietrich A. Stephan, PhD
Employees
Employees
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2009
Founded2009
Employees
Employees

OHRP Key Statistics

Market cap
7.65M
Market cap7.65M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
81.61K
Average volume81.61K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.19
52 Week high$3.19
52 Week low
$0.184
52 Week low$0.184
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.